🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
SITISVEAL stablish the hypothesis that treatment with Tislelizumab + Sitrav...
Status
Completed
Location
Hospital Universitario Virgen de la Macarena
Start Date
2022-09-23
Trial ID
NCT05542342
Treatments Being Tested
A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild, Mo...
Status
Completed
Location
Orange County Research Center
Start Date
2021-03-12
Trial ID
NCT04772612
Treatments Being Tested
The study will evaluate the clinical activity of PD-(L)1 Checkpoint Inhibit...
Status
Terminated
Location
The University of Arizona Cancer Center
Start Date
2018-09-11
Trial ID
NCT03606174
Treatments Being Tested
A Phase 1 Open-label, Two-cohort, One-sequence Crossover Study to Investiga...
Status
Completed
Location
Labcorp Drug Development Clinical Research Unit
Start Date
2022-02-02
Trial ID
NCT05255276
Treatments Being Tested
This study evaluates the efficacy of sitravatinib in patients with metastat...
Status
Terminated
Location
Baylor College of Medicine
Start Date
2021-09-22
Trial ID
NCT04123704
Treatments Being Tested
The trial consists of a series of parallel multi-centre single arm phase II...
Status
Completed
Location
Aberdeen Royal Infirmary
Start Date
2015-05-13
Trial ID
NCT02664935
This study aims to evaluate the 1-year progression free survival (PFS) rate...
Status
Terminated
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-10
Trial ID
NCT05176925
Treatments Being Tested
The study aimed to evaluate the efficacy and safety of sitravatinib in comb...
Status
Terminated
Location
Anhui Provincial Hospital South Brance
Start Date
2022-10-03
Trial ID
NCT05461794
Treatments Being Tested
This is a study of pembrolizumab in combination with sitravatinib in adult ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-09-08
Trial ID
NCT05419817
Treatments Being Tested
An Open-label, Randomized, Three-period, Crossover Study of the Effect of F...
Status
Completed
Location
Covance Clinical Research Unit, Inc.
Start Date
2021-03-15
Trial ID
NCT04800614
Treatments Being Tested